Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation

被引:56
作者
Chen, SH
Garber, DA
Schaffer, PA
Knipe, DM
Coen, DN
机构
[1] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
[3] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan
[4] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA
关键词
D O I
10.1006/viro.2000.0643
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Infection of mouse trigeminal ganglia by herpes simplex virus induces cytokine expression that persists long after infectious virus or viral antigens become undetectable. To examine mechanisms underlying this phenomenon, we used a thymidine kinase mutant, d/sptk, which fails to replicate in ganglia and does not reactivate upon ganglionic explant. Using quantitative reverse transcriptase-polymerase chain reaction assays, we found that levels of interferon-gamma and tumor necrosis factor-alpha transcripts in d/sptk-infected ganglia were lower than those in wild type-infected ganglia, but were significantly (eight- to 10-fold) higher than those in mock-infected ganglia from Day 3 to Day 100 postinfection. We also studied latency-associated transcript (LAT) negative mutants that exhibit increased expression of productive cycle transcripts in ganglia. Ganglia infected with these mutants contained levels of cytokine transcripts similar to those in wild type-infected ganglia; any increases in Viral antigen expression mediated by the LAT deletion were not accompanied by increased cytokine expression. Thus, neither viral replication, the ability to reactivate, nor LAT expression in ganglia is required for persistent elevated cytokine expression. The results provide indirect evidence that low-level expression of viral productive cycle genes in neurons can provide signals that elicit cytokine expression. (C) 2000 Academic Press.
引用
收藏
页码:207 / 216
页数:10
相关论文
共 44 条
[1]   ACYCLOVIR NEUROTOXICITY - CLINICAL-EXPERIENCE AND REVIEW OF THE LITERATURE [J].
ADAIR, JC ;
GOLD, M ;
BOND, RE .
SOUTHERN MEDICAL JOURNAL, 1994, 87 (12) :1227-1231
[2]   Role for gamma interferon in control of herpes simplex virus type 1 reactivation [J].
Cantin, E ;
Tanamachi, B ;
Openshaw, H .
JOURNAL OF VIROLOGY, 1999, 73 (04) :3418-3423
[3]   GAMMA-INTERFERON EXPRESSION DURING ACUTE AND LATENT NERVOUS-SYSTEM INFECTION BY HERPES-SIMPLEX VIRUS TYPE-1 [J].
CANTIN, EM ;
HINTON, DR ;
CHEN, J ;
OPENSHAW, H .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4898-4905
[4]   The persistent elevated cytokine mRNA levels in trigeminal ganglia of mice latently infected with HSV-1 are not due to the presence of latency associated transcript (LAT) RNAs [J].
Carr, DJJ ;
Halford, WP ;
Veress, LA ;
Noisakran, S ;
Perng, GC ;
Wechsler, SL .
VIRUS RESEARCH, 1998, 54 (01) :1-8
[5]   Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant [J].
Chen, SH ;
Cook, WJ ;
Grove, KL ;
Coen, DM .
JOURNAL OF VIROLOGY, 1998, 72 (08) :6710-6715
[6]   A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus [J].
Chen, SH ;
Kramer, MF ;
Schaffer, PA ;
Coen, DM .
JOURNAL OF VIROLOGY, 1997, 71 (08) :5878-5884
[7]   SENSITIVITY OF ARABINOSYLADENINE-RESISTANT MUTANTS OF HERPES-SIMPLEX VIRUS TO OTHER ANTIVIRAL DRUGS AND MAPPING OF DRUG HYPERSENSITIVITY MUTATIONS TO THE DNA-POLYMERASE LOCUS [J].
COEN, DM ;
FLEMING, HE ;
LESLIE, LK ;
RETONDO, MJ .
JOURNAL OF VIROLOGY, 1985, 53 (02) :477-488
[8]   THYMIDINE KINASE-NEGATIVE HERPES-SIMPLEX VIRUS MUTANTS ESTABLISH LATENCY IN MOUSE TRIGEMINAL GANGLIA BUT DO NOT REACTIVATE [J].
COEN, DM ;
KOSZVNENCHAK, M ;
JACOBSON, JG ;
LEIB, DA ;
BOGARD, CL ;
SCHAFFER, PA ;
TYLER, KL ;
KNIPE, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4736-4740
[9]  
DEMIRANDA P, 1992, ANTIVIR CHEM CHEMOTH, V3, P1
[10]  
DOHERTY PC, 1999, VIRAL PATHOGENESIS, P143